6.1(top 5%)
impact factor
1.4K(top 20%)
papers
71.9K(top 5%)
citations
124(top 5%)
h-index
6.5(top 5%)
impact factor
1.7K
all documents
76.4K
doc citations
178(top 5%)
g-index
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | Sexual dimorphism of body composition | Best Practice and Research in Clinical Endocrinology and Metabolism | 2007 | 649 |
2 | Cellular and molecular mechanisms of mitochondrial function | Best Practice and Research in Clinical Endocrinology and Metabolism | 2012 | 542 |
3 | Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitamin D3: Genomic and non-genomic mechanisms | Best Practice and Research in Clinical Endocrinology and Metabolism | 2011 | 527 |
4 | Worldwide vitamin D status | Best Practice and Research in Clinical Endocrinology and Metabolism | 2011 | 500 |
5 | Maternal thyroid hormones early in pregnancy and fetal brain development | Best Practice and Research in Clinical Endocrinology and Metabolism | 2004 | 467 |
6 | Epidemiology of thyroid nodules | Best Practice and Research in Clinical Endocrinology and Metabolism | 2008 | 454 |
7 | The impact of obesity on psychological well-being | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 418 |
8 | Sleep duration and cardiometabolic risk: A review of the epidemiologic evidence | Best Practice and Research in Clinical Endocrinology and Metabolism | 2010 | 391 |
9 | Male infertility: Pathogenesis and clinical diagnosis | Best Practice and Research in Clinical Endocrinology and Metabolism | 2011 | 389 |
10 | Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to come | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 382 |
11 | Estrogen receptor alpha and beta in health and disease | Best Practice and Research in Clinical Endocrinology and Metabolism | 2015 | 378 |
12 | Sleep loss and inflammation | Best Practice and Research in Clinical Endocrinology and Metabolism | 2010 | 366 |
13 | Iodine intake as a determinant of thyroid disorders in populations | Best Practice and Research in Clinical Endocrinology and Metabolism | 2010 | 360 |
14 | The effect of vitamin D on bone and osteoporosis | Best Practice and Research in Clinical Endocrinology and Metabolism | 2011 | 359 |
15 | Disorders of body water homeostasis | Best Practice and Research in Clinical Endocrinology and Metabolism | 2003 | 348 |
16 | Weight discrimination and bullying | Best Practice and Research in Clinical Endocrinology and Metabolism | 2013 | 344 |
17 | Alterations in fuel metabolism in critical illness: hyperglycaemia | Best Practice and Research in Clinical Endocrinology and Metabolism | 2001 | 304 |
18 | Noonan syndrome and clinically related disorders | Best Practice and Research in Clinical Endocrinology and Metabolism | 2011 | 303 |
19 | Human fat cell lipolysis: Biochemistry, regulation and clinical role | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 293 |
20 | Adipose tissue dysfunction contributes to obesity related metabolic diseases | Best Practice and Research in Clinical Endocrinology and Metabolism | 2013 | 281 |
21 | Clinical management of adrenocortical carcinoma | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 272 |
22 | Adiponectin receptors: A review of their structure, function and how they work | Best Practice and Research in Clinical Endocrinology and Metabolism | 2014 | 272 |
23 | Melatonin: clinical relevance | Best Practice and Research in Clinical Endocrinology and Metabolism | 2003 | 271 |
24 | Adipose tissue: a regulator of inflammation | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 269 |
25 | Metachromatic leukodystrophy: Disease spectrum and approaches for treatment | Best Practice and Research in Clinical Endocrinology and Metabolism | 2015 | 268 |
26 | Endometrium in PCOS: Implantation and predisposition to endocrine CA | Best Practice and Research in Clinical Endocrinology and Metabolism | 2006 | 267 |
27 | Disorders of sex development: a new definition and classification | Best Practice and Research in Clinical Endocrinology and Metabolism | 2008 | 261 |
28 | Pathways of endocrine disruption during male sexual differentiation and masculinisation | Best Practice and Research in Clinical Endocrinology and Metabolism | 2006 | 253 |
29 | Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapy | Best Practice and Research in Clinical Endocrinology and Metabolism | 2019 | 251 |
30 | Epidemiology of osteoporosis | Best Practice and Research in Clinical Endocrinology and Metabolism | 2008 | 248 |
31 | Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination | Best Practice and Research in Clinical Endocrinology and Metabolism | 2007 | 245 |
32 | Methods for clinical assessment of insulin sensitivity and β-cell function | Best Practice and Research in Clinical Endocrinology and Metabolism | 2003 | 239 |
33 | Genetics of congenital adrenal hyperplasia | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 235 |
34 | Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 229 |
35 | Adipogenesis: cellular and molecular aspects | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 226 |
36 | The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status | Best Practice and Research in Clinical Endocrinology and Metabolism | 2004 | 225 |
37 | The metabolic consequences of childhood obesity | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 217 |
38 | Pitfalls in the measurement and interpretation of thyroid function tests | Best Practice and Research in Clinical Endocrinology and Metabolism | 2013 | 216 |
39 | Economic costs of overweight and obesity | Best Practice and Research in Clinical Endocrinology and Metabolism | 2013 | 214 |
40 | Link between obesity and type 2 diabetes | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 211 |
41 | Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus | Best Practice and Research in Clinical Endocrinology and Metabolism | 2007 | 211 |
42 | Role of sleep duration in the regulation of glucose metabolism and appetite | Best Practice and Research in Clinical Endocrinology and Metabolism | 2010 | 210 |
43 | Vitamin D and the brain | Best Practice and Research in Clinical Endocrinology and Metabolism | 2011 | 210 |
44 | Behavioural determinants of obesity | Best Practice and Research in Clinical Endocrinology and Metabolism | 2005 | 209 |
45 | New insights into thyroid hormone action | Best Practice and Research in Clinical Endocrinology and Metabolism | 2007 | 208 |
46 | Pathophysiology of insulin resistance | Best Practice and Research in Clinical Endocrinology and Metabolism | 2006 | 206 |
47 | Multiple endocrine neoplasia type 1 (MEN1) | Best Practice and Research in Clinical Endocrinology and Metabolism | 2010 | 206 |
48 | Mechanism of action of inhibitors of dipeptidyl-peptidase-4 (DPP-4) | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 205 |
49 | An introduction to the endocannabinoid system: from the early to the latest concepts | Best Practice and Research in Clinical Endocrinology and Metabolism | 2009 | 203 |
50 | Iodine excess | Best Practice and Research in Clinical Endocrinology and Metabolism | 2010 | 200 |